Join to View Full Profile
2165 Deyerle Rd SWRoanoke, VA 24018
Dr. Currie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Currie is a retired hematologist/oncologist based in southwest VA, with an educational background that includes fellowships in Hematology and Medical Oncology at Duke University Hospital and the University at Buffalo, as well as a residency in Internal Medicine at Duke University and Durham VA Hospitals. He graduated from the University of Texas Southwestern Medical School in 1978. Dr. Currie has contributed to the field with several publications, including studies on neutrophils, complement, coagulation, immunosenescence, and complications related to COVID-19. Though retired from practice and teaching residents, he remains very interested in the dramatic advances in Hematology, Immunology, and Medical Oncology.
Education & Training
University at BuffaloFellowship, Hematology and Medical Oncology, 1982 - 1983
Duke University HospitalFellowship, Hematology and Medical Oncology, 1981 - 1982- Duke University HospitalResidency, Internal Medicine, 1978 - 1981
University of Texas Southwestern Medical SchoolClass of 1978
Certifications & Licensure
NC State Medical License 1978 - 2026
TX State Medical License 1978 - 2026
VA State Medical License 1997 - 2026
GA State Medical License 1992 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsHyperhemolysis in the Setting of Mixed-Autoimmune Hemolytic Anemia: A Rare Complication of COVID-19.Sonya Narula, Sean Winkle, Kenneth Brand, Farhan Shah, Priscilla Fujikawa
Cureus. 2021-12-01 - 18 citationsThe CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system.Susana S. Correia, Guang Liu, Sarah Jacobson, Sylvie G. Bernier, Jenny Tobin
Journal of Neuroinflammation. 2021-09-18 - 20 citationsThe CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals its Therapeutic Potential in Neurodegenerative Diseases.Susana S. Correia, Rajesh R. Iyengar, Peter Germano, Kim Tang, Sylvie G. Bernier
Frontiers in Pharmacology. 2021-05-24
Press Mentions
Peelable Thermal Interface Material (TIM) from Henkel Recognized with Industry AccoladeDecember 11th, 2018
Ironwood Pharmaceuticals Promotes Dr. Mark Currie to Senior Vice President, Chief Scientific Officer, and President of R&DFebruary 11th, 2013
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
